絞り込み

17799

広告

新型コロナ 寮の部員ら88人感染 松江の高校サッカー部 (毎日新聞)

松江市で新型コロナウイルスへの感染が明らかになった91人について、市と島根県は9日夜、88人が立正大淞南(しょうなん)高校(北村直樹校長、生徒数309人)のサッ...

  1. 新型コロナ 両陛下、国民との交流模索 専...
  2. 生きる:小児がん征圧キャンペーン オンラ...
  3. 新型コロナ 両陛下、国民との交流模索 専...
  4. 異変のシグナル:「カネミ油症」救済になお...

ニュース一覧

Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines.

著者 Sasaki R , Kanda T , Fujisawa M , Matsumoto N , Masuzaki R , Ogawa M , Matsuoka S , Kuroda K , Moriyama M
Int J Mol Sci.2020 May 09 ; 21(9):.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (2view , 0users)

Full Text Sources

Miscellaneous

Research Materials

Multiple kinase inhibitors are available for patients with advanced hepatocellular carcinoma (HCC). It is largely unknown whether regorafenib or lenvatinib modulates innate immunity including Toll-like receptor (TLR)-signaling pathways in HCC. We performed real-time RT-PCR to investigate 84 TLR-associated gene expression levels and compared these gene expression levels in each hepatoma cells treated with or without regorafenib or lenvatinib. In response to regorafenib, nine and 10 genes were upregulated in Huh7 and HepG2 cells, respectively, and only C-X-C motif chemokine ligand 10 was upregulated in both cell lines. A total of 14 and 12 genes were downregulated in Huh7 and HepG2 cells, respectively, and two genes (Fos proto-oncogene, AP-1 transcription factor subunit, and ubiquitin conjugating enzyme E2 N) were downregulated in both cell lines. In response to lenvatinib, four and 16 genes were upregulated in Huh7 and HepG2 cells, respectively, and two genes (interleukin 1 alpha and TLR4) were upregulated in both cells. Six and one genes were downregulated in Huh7 and HepG2, respectively, and no genes were downregulated in both cell lines. In summary, regorafenib and lenvatinib affect TLR signaling pathways in human hepatoma cell lines. Modulation of TLR signaling pathway may improve the treatment of HCC patients with refractory disease.
PMID: 32397371 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード